Valproate in a Newly Pregnant Patient With Epilepsy
A 27-year-old woman presents to the pharmacy 8 weeks pregnant (confirmed by ultrasound) with a 6-year history of juvenile myoclonic epilepsy. She takes valproate 500 mg twice daily and has been seizure-free for 2 years. She has not yet seen an obstetrician and asks whether she should "just stop the valproate now to protect the baby." She also takes folic acid 0.4 mg daily, has no other medications, does not smoke or drink, and has no family history of neural tube defects. Her seizures in the past have been generalized tonic-clonic and have occurred without warning. She is tearful and says she read online that valproate causes birth defects.
1. Explain the risk of valproate in pregnancy in a way that is accurate and that directly addresses her question about stopping abruptly.
Read the worked answer
- Validate the concern and be specific, not vague. Valproate is one of the most teratogenic antiepileptic drugs: the absolute risk of major congenital malformations is roughly 10% (compared with about 2–3% baseline), and the risk of neurodevelopmental disorders (autism spectrum, lowered IQ) is around 30–40% in some cohorts. Risk is dose-dependent and rises notably above about 1000 mg/day; she is on exactly 1000 mg/day, so dose reduction matters.
- The critical window has already begun. Neural tube closure occurs at about 4–6 weeks' gestation - she is 8 weeks, so the highest-risk period for structural malformation has largely passed. This does not remove the risk for later effects (cardiac, limb, urogenital, neurodevelopmental), and it is not a reason to delay action.
- Answer her actual question directly: do not stop suddenly. Abrupt withdrawal of an antiepileptic in a patient with a history of generalized tonic-clonic seizures risks status epilepticus and injury to both mother and fetus; uncontrolled generalized seizures carry real fetal and maternal mortality. The safest plan is a supervised, planned change, not an immediate stop.
- Set expectations honestly: she may not be able to be completely off valproate, and the goal is the lowest effective dose of the safest effective drug, not necessarily zero drug.
2. Outline the medication plan you would discuss with her and her prescribers, and explain the reasoning behind each element.
Read the worked answer
- Same-day referral, not a waiting list: contact her neurologist and family physician (and the obstetric provider) the same day. In many jurisdictions valproate in pregnancy requires documented specialist review; the pharmacist's job is to make the referral happen and to ensure she is not left without a plan.
- Folic acid: increase to 5 mg daily (high-dose supplementation is standard for women on antiepileptics and for pre-conception/pregnancy risk reduction). Continue through at least the first trimester.
- Consider switching to lamotrigine or levetiracetam - the two best-evidenced alternatives in pregnancy for generalized epilepsy. Both have substantially lower malformation rates and more reassuring neurodevelopmental data, though lamotrigine levels fall markedly in pregnancy (increased clearance), requiring level monitoring and possible dose increases, especially in the third trimester and postpartum.
- If a switch is chosen, do it by slow cross-taper, not by simultaneous stop and start, and do it with a plan for what to do if myoclonic jerks recur. Switching anticonvulsants during pregnancy itself carries a seizure risk; this is a benefit–risk decision for the neurologist with her.
- If valproate continues, use the lowest effective dose, consider a modified-release formulation, and do not split or self-adjust doses; document the shared decision.
- Prenatal screening is part of the plan: high-dose folate, detailed anatomy ultrasound at 18–20 weeks, consider fetal echocardiography, and maternal serum screening. Note that valproate exposure can affect maternal serum AFP interpretation - flag it so the result is not misread.
- Counselling points: do not stop or change doses on her own, call immediately if seizure activity changes, avoid driving restrictions if seizures recur, and re-engage early postpartum (levels of lamotrigine fall after delivery).
3. What would you say and do in the next 10 minutes of this visit, given that she is tearful and has no obstetric provider yet?
Read the worked answer
- Acknowledge emotion first, then inform. "It makes sense that you're frightened - you read something real. Nothing you did caused this, and the most important thing right now is that you don't stop your medicine on your own." Information delivered before reassurance tends to be heard as blame.
- Make one thing happen today: book or facilitate contact with a neurologist and an obstetric provider, write down names and phone numbers, and get her permission to send a note. Offer to call while she is present. A patient with no prenatal care at 8 weeks is a time-critical gap.
- Give her something concrete to take home: start or confirm prescriptions for folic acid 5 mg daily, a written summary of what was discussed, and clear instructions on when to seek urgent care (prolonged seizure, injury, vaginal bleeding, reduced fetal movement later on).
- Use teach-back: ask her to tell you what she will do if she has a seizure or runs out of medication, to confirm she has understood "do not stop on your own."
- Check the practical issues she may not raise: can she afford the medications, does she have transportation, does she have someone at home, and does she want a documented plan for her employer or school.
- Follow up actively - a phone call in a few days, not an open invitation to call. Document the referral, the counselling, and the plan in the pharmacy record so the next clinician sees the full picture.